Aetna stock: buy or sell?
November 28th, 2018
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions.
Should I buy Aetna stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
These 2 buy setups work for Aetna stock right now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Aetna stock a buy?
Financial institutions and banks post stock ratings everyday.Unfortunately, we couldn't find any rating for AET stock for the last month.
Aetna stock analysis
After several days of continuous hikes in past weeks, Aetna stayed constant 0.33% to $212.70.
After reaching all time highs , Aetna stayed steady 0.33% to $212.70. AET shows a sign of strength in the short-term after finally breaking out above $210.90 and marking a new rising bottom. AET price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock. , AET hit new all time highs, pushing higher previous ATH of $212.00 recorded . New ATHs are usual entry points for many trading setups as there aren't higher resistences.
Aetna soared 3.57% late November 2018 and set a new all time high at $213.36. Early November AET boosted a cool 5.33% in just one week.
Aetna stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Late October 2018 AET price bounced up over the SMA of 20 weeks that acted as support stopping new slides.
Aetna stock price history
Aetna IPO was on January 4th, 2018 at $181.87 per share1. Since then, AET stock grew a 17.00%, with an average of 8.50% per year. If you had invested right after AET's IPO a $1,000 in Aetna stock in 2018, it would worth $170.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Aetna stock historical price chart
AET stock reached all-time highs with a price of $213.36.
Aetna stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price forecast for Aetna stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, Aetna presented its financial report, posting a tiny climb for the Earnings per Share (EPS) ratio. Analyst were expecting $2.84 per share, but Aetna posted $2.96. Aetna is reporting earnings for 2018-Q4 . We don't currently have any forecast for next quarter EPS ratio. Keep tuned in the coming weeks to learn about AET's EPS estimate.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2017, Aetna annual revenues declined a fateful -4.15% to $60,535.00 M dollars from $63,155.00 marked in 2016. Slightly better, its earnings margin (compared to revenues) remained stable to 3.15%, that is $1,904.00 million. To have an updated picture of the financial situation of Aetna, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2018-Q3 that can be compared to 2017 fiscal year results. Annual Aetna TTM sales up to September 2018 were $61,233.00 and income was $3,665.00 million dollars. When comparing this TTM figures with the last reported annuality, we can review Aetna business evolution since December 2017: Annual turnover up to September, compared to lastest yearly report, gained a tiny 1.15%. On the other hand, profit margin (net income/sales) appreciated at 3.15%.
|2013||$47,330 M||-||$1,910 M4.0%||-|
|2014||$58,003 M||22.55%||$2,041 M3.5%||6.85%|
|2015||$60,337 M||4.02%||$2,390 M4.0%||17.12%|
|2016||$63,155 M||4.67%||$2,271 M3.6%||-4.99%|
|2017||$60,535 M||-4.15%||$1,904 M3.1%||-16.16%|
|TTM||$61,233 M||1.15%||$3,665 M6.0%||92.49%|
Quarterly financial resultsAetna posted $15,484.00 million in sales for 2018-Q3, a -0.49% less compared to previous quarter. Reported quarter income marked $1,000.00 million with a profit margin of 6.46%. Profit margin decreased a -1.33% compared to previous quarter when profit margin was 7.79%. When comparing turnover to same quarter last year, Aetna sales marked a good increase and stepped up a 3.27%.
|2016-Q4||$15,750 M||-||$139 M0.9%||-|
|2017-Q1||$15,170 M||-3.68%||$-381 M-2.5%||-374.10%|
|2017-Q2||$15,520 M||2.31%||$1,200 M7.7%||-414.96%|
|2017-Q3||$14,994 M||-3.39%||$838 M5.6%||-30.17%|
|2017-Q4||$14,853 M||-0.94%||$244 M1.6%||-70.88%|
|2018-Q1||$15,335 M||3.25%||$1,209 M7.9%||395.49%|
|2018-Q2||$15,561 M||1.47%||$1,212 M7.8%||0.25%|
|2018-Q3||$15,484 M||-0.49%||$1,000 M6.5%||-17.49%|
Aetna ownershipWhen you are planning to invest in shares of a company, it's always worth to overview its ownership structure.
Aetna shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a of all shares.
The following table compares ownership indicators for other stocks related to Aetna:
|Market cap||$0.0 M|
|Total shares||0.0 M|
|Float shares||0.0 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Wednesday, November 28th, 2018|
|Day range||$211.79 - $213.36|
|Average true range||$2.52|
|50d mov avg||$203.39|
|100d mov avg||$199.24|
|200d mov avg||$0.00|
Aetna performanceTo better understand Aetna performance you must becnhmark its gains with other related stocks in same sector or industry. In the following table, we compare Aetna to :
Aetna competitorsUnfortunately, we could not find any public company that could be defined as Aetna competitor. This doesn't mean Aetna does not have any competitor in the market, it's just we could not detected it.
Latest Aetna stock news
- InvestorPlaceAetna Uncertainty Is Keeping CVS Stock Way UndervaluedJune 17, 2019
- InvestorPlaceCan CVS Stock Overcome the Latest Wrench in Its Aetna Merger?June 13, 2019
- InvestorPlaceDoes Progress On Aetna Integration Make CVS Health Stock A Buy In May?May 21, 2019
- InvestorPlaceCVS Stock Faces Challenges With Aetna Merger … So Buy It!May 20, 2019
- InvestorPlaceAfter Aetna Merger, The Benefits Outweigh the Risks in CVS StockDecember 3, 2018